Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2007; 13(48): 6593-6597
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6593
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6593
Time | Group A | Group B | P-value2 | ||
mean ± SD | P-value1 | mean ± SD | P-value1 | ||
Pre-treatment | 2.45 ± 0.41 | 2.40 ± 0.51 | 0.734 | ||
Post-treatment | |||||
1 wk | 7.26 ± 0.96 | < 0.001 | 1.77 ± 0.38 | < 0.001 | < 0.001 |
2 wk | 6.42 ± 1.02 | < 0.001 | 1.68 ± 0.39 | < 0.001 | < 0.001 |
1 mo | 6.31 ± 0.83 | < 0.001 | 1.72 ± 0.65 | < 0.001 | < 0.001 |
2 mo | 6.03 ± 0.93 | < 0.001 | 1.91 ± 0.73 | 0.0032 | < 0.001 |
3 mo | 5.36 ± 0.64 | < 0.001 | 2.02 ± 0.48 | 0.013 | < 0.001 |
- Citation: Huang JH, Gao F, Gu YK, Li WQ, Lu LW. Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization. World J Gastroenterol 2007; 13(48): 6593-6597
- URL: https://www.wjgnet.com/1007-9327/full/v13/i48/6593.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i48.6593